CAPRICOR THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase Decrease In Operating Lease Liability of -$85.35 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2022-05-11
- CAPRICOR THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2022-03-31 was -$85.35K.
- CAPRICOR THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2021-03-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2021 was -$81.33K.
- CAPRICOR THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2020 was $0.00.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|
| 2022-03-31 | -$85.35K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | -$81.33K 10-K · filed 2022-03-11 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |